Lataa...
Spotlight on cabozantinib for previously untreated advanced renal cell carcinoma: evidence to date
Melissa Bersanelli, Francesco Leonardi, Sebastiano Buti University Hospital of Parma, Medical Oncology Unit, Parma, Italy Background: In the past few years, new drugs made their appearance in the first-line setting of treatment for metastatic renal cell carcinoma (mRCC), and cabozantinib is one amon...
Tallennettuna:
| Päätekijät: | , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Dove Medical Press
2018-09-01
|
| Sarja: | Cancer Management and Research |
| Aiheet: | |
| Linkit: | https://www.dovepress.com/spotlight-on-cabozantinib-for-previously-untreated-advanced-renal-cell-peer-reviewed-article-CMAR |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|